SCHEMBL29930558

SCHEMBL29930558

C[Si](C)(C)CCOCn1nc(-c2cnn(Cc3ccccc3)c2)c2cc(Br)cnc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.39
CREBBP Q92793 7/20 0.37
PGK1 P00558 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALK Q9UM73 1/20 0.35
PIK3CD O00329 2/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29935301 0.87 DGAT1 (0.33) DYRK1B
SCHEMBL1592834 0.86 MERTK (0.39) DYRK1BALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL29930809 0.81 DGAT1 (0.37) DYRK1BALDH1A1NPSR1
SCHEMBL29930508 0.79 DGAT1 (0.36) DYRK1B
SCHEMBL29930779 0.78 AXL (0.41) DYRK1BL3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL29930407 0.78 DYRK1B (0.39) DYRK1BCREBBP
SCHEMBL29930401 0.77 DYRK1B (0.40) DYRK1B
SCHEMBL29930815 0.77 AXL (0.41) DYRK1BALDH1A1NPSR1PIK3CDPIK3CA
SCHEMBL29930730 0.77 L3MBTL1 (0.45) DYRK1BL3MBTL1CREBBPADORA2AADORA1
SCHEMBL29930917 0.76 DYRK1B (0.38) DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed